HOME › DRUGS › DONANEMAB
ACTIVE SUBSTANCE / INN

DONANEMAB

Brand name(s): Kisunla
EMA LISTED
AUTHORISED
Alzheimer Disease;Cognitive Dysfunction
ACTIVE SUBSTANCE
Donanemab
REGULATORS
EMA
SPONSORS / MAH
Eli Lilly Nederland B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KisunlaEli Lilly Nederland B.V.Authorised24/09/2025Alzheimer Disease;Cognitive Dysfunction

FULL INTELLIGENCE ON DONANEMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →